Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$1M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 3 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 10 most recent Form 4 transactions.
| May 29 | KNSA | Kiniksa Pharmaceuticals… | AGRANT◆ | 12,158 | — | — | — | Open the original filing on SEC.gov |
| May 29 | KNSA | Kiniksa Pharmaceuticals… | MEXER | 2,799 | — | — | +22.3% | Open the original filing on SEC.gov |
| Apr 28 | KNSA | Kiniksa Pharmaceuticals… | MEXER◷◆ | 13,099 | — | — | — | Open the original filing on SEC.gov |
| Apr 28 | KNSA | Kiniksa Pharmaceuticals… | SSELL◷ | 13,099 | $50.10 | $656.3K | -51.1% | Open the original filing on SEC.gov |
| Apr 28 | KNSA | Kiniksa Pharmaceuticals… | MEXER◷ | 13,099 | $14.33 | $187.7K | +104.4% | Open the original filing on SEC.gov |
| Apr 6 | KNSA | Kiniksa Pharmaceuticals… | MEXER◷◆ | 6,901 | — | — | — | Open the original filing on SEC.gov |
| Apr 6 | KNSA | Kiniksa Pharmaceuticals… | SSELL◷ | 6,901 | $50.00 | $345.1K | -35.5% | Open the original filing on SEC.gov |
| Apr 6 | KNSA | Kiniksa Pharmaceuticals… | MEXER◷ | 6,901 | $14.33 | $98.9K | +55.0% | Open the original filing on SEC.gov |